Taiji Group is based on Fuling Pharmaceutical Factory, with Fuling Pharmaceutical Factory as the core, and developed from a small workshop with an annual output value of several hundred thousand yuan. The backbone Taiji Group consists of Sichuan Taiji Pharmaceutical Co., Ltd., Taiji Group Chongqing Company, Taiji Industrial Development Company, Taiji Product Suppression Company, Taiji Packaging and Printing Company, Taiji Transportation Company and Taiji Beverage Company. 1 9 9 6, the output value of the complete works was 800 million. Become a diversified and large-scale enterprise with drug production as its main task and cross-regional and cross-industry. The pharmaceutical industry is dominated by traditional Chinese medicines produced by Jituan Company.
Taiji Tongtian Liquid, Jizhi Syrup, Jizhi Granule, Erkangning, Chantai, Huoxiang Zhengqi Liquid? And so on, and exported to Japan, Singapore, Malaysia, Hong Kong and other countries and regions. Before the end of the project, Taiji Group had more than 6 0 kinds of Chinese and western medicines and was developing more than 2 0 new products. The research and development of the second generation product of Taiji Tian Tong Liquid was included in the national key scientific and technological project in the Ninth Five-Year Plan. Because of his outstanding achievements and good leadership, he was rated as one of the top ten outstanding artists in Sichuan by 1 9 9 5, became a medical expert enjoying state subsidies, and was rated as an outstanding entrepreneur by state administration of traditional chinese medicine and state administration of traditional chinese medicine.
GMP certification has just come to an end, followed by GSP certification. At such a critical juncture, it coincides with the national macro-control and the tight money supply. In recent years, many enterprise groups in the pharmaceutical industry began to feel the pressure of "lack of money", and their production and operation were gradually stretched. In recent years, Taiji Group, which has always declared that it will not expand on a large scale, has begun to show its unique charm in the strategic deployment of steady growth. From June 5438 to September this year, Taiji Group achieved sales of 5.288 billion yuan, up 20% year-on-year, while the national pharmaceutical economic situation declined as a whole.
Taiji Group has developed rapidly in recent years, but its expansion is steady. Completely adhering to the principle that only enterprises that are beneficial to the development of the group, can make up for the shortcomings of the group itself, or are conducive to the formation of new economic growth points or the adjustment of enterprise product structure will consider mergers and acquisitions. The resources acquired by Taiji are concentrated in the pharmaceutical industry. Its controllability is very strong, which not only makes the acquired enterprises embark on the road of rapid development, but more importantly, after integration, Taiji Group has formed the most perfect pharmaceutical industry chain in China.
From 65438 to 0997, Taiji Group successfully acquired Tongjunge, which made up for its shortcomings in the field of medicine and commerce and provided a smoother channel for Taiji products. At the same time, its advanced management concept and business philosophy have also given Tongjunge a new life as a century-old brand. After several years of operation, Tongjunge has become a well-known pharmaceutical commercial enterprise in China, with sales increasing from 470 million yuan in the year of acquisition to 3.5 billion yuan in 2003 and expected to exceed 5 billion yuan in 2004. Tongjunge chain pharmacies will reach 5,000 this year, and its subordinate pharmaceutical logistics centers in Chongqing, Chengdu, Shanghai and other places will become an important breakthrough for Taiji Group to develop in the next stage. Among them, Chengdu western medicine will achieve sales of 654.38+0.5 billion yuan this year, and Chongqing Nan 'an Tongjunge Wholesale Company will achieve sales of 654.38+0 billion yuan. The regional pharmaceutical logistics centers in Luzhou, Mianyang, Deyang, Zigong and Yongchuan, which have been put into operation, will have sales of more than 654.38 billion yuan next year; At the same time, the company is actively building regional logistics centers such as Beijing, Shanghai, Guangzhou and Anhui Taihe to seize the national pharmaceutical market. In 2002, Taiji set up a factory in Macao, striving to make Macao a testing ground for the unitary and global development of the group and a bridgehead for Taiji to enter the international market.
In 2002, Taiji Group completed the acquisition of Southwest Pharmaceutical, and realized the strategic concept of Taiji's integration of traditional Chinese and western medicine, which provided an important position for Taiji to strive for international cooperation in the next stage and laid the foundation for the comprehensive cooperation between Taiji Group and large international pharmaceutical enterprises. After Taiji Group entered Southwest Pharmaceutical Industry, it carried out a series of internal resource integration, which ended the low-speed development history of Southwest Pharmaceutical Industry for nearly 10, with an increase of 25% in 2003 and annual sales of nearly 500 million yuan.
The word "Tai Chi" emphasizes the problem of "balance". In order to make the whole Taiji develop in a balanced way and form a comprehensive enterprise integrating science, industry and trade, Taiji has integrated several very powerful medical research institutions in China, such as Chongqing Institute of Traditional Chinese Medicine and Taiji Medical Research Institute, and has made a lot of reserves for the development of new products, and new products are constantly on the market.
Bai, chairman of Taiji Group, summarized the post-acquisition integration work into two points: First, the most important point is to change the concept. Enterprises should be keenly aware of the rapid changes in market demand and guide all their business activities with market demand.
Secondly, we should pay attention to marketing. "Marketing is an important means to deal with the current domestic pharmaceutical market. Many enterprises, such as Southwest Pharmaceutical, have good product resources before acquisition, but their sales are not good. After introducing good marketing concepts, this situation has been quickly improved. " At the beginning of June this year, Taiji Group announced that it had formed a sales alliance with Shanghai Leiyunshang and Guangyao. Taiji's 300 direct stores have officially hung up the signboard of "Sales Alliance Pharmacy", and set up sales and display counters for products of affiliated enterprises in the stores to share business networks and information with each other.
Generally speaking, the expansion speed of Taiji Group is steady and professional. They are integrating while expanding. The purpose is to fully integrate the acquired enterprises with the original resources, give full play to their respective advantages, and achieve the goal of 1+ 1 greater than 2. In the past two years, Taiji has stopped the pace of expansion, devoted itself to integration, and pursued "high technology, high efficiency and high benefit" to build the most perfect pharmaceutical industry chain in China.
Bai said that expansion is a double-edged sword. In the process of enterprise expansion, we should be very clear about the position and development stage of the enterprise, clearly evaluate our own strength, fully grasp the market rules, and formulate a unique model suitable for our own development.
With GMP and GSP certification coming one after another, the country's money is tight and the capital environment is unfavorable, Taiji Group is doing quite well in all aspects and is developing rapidly on a benign development track. "Taiji" has become a well-known trademark in China; In the first half of the year, Taiji Group entered the "Top 500 Chinese Enterprises" (ranked 292nd), which proved that Taiji was the best in the past and strengthened its confidence in the future.
As one of the "Top 500 Chinese Enterprises", Taiji Group currently has assets of 654.38+06 billion yuan; There are three listed companies: Taiji Group -600 129 Tongjunge -00059 1 Southwest Pharmaceutical-600666; Has more than 3,000 large pharmacies; 13000 employees, 1 1 pharmaceutical factory, 16 pharmaceutical commercial company.
However, Bai said that although Taiji Group ranks among the top 500 Chinese enterprises, there is still a certain gap with Shanghai Pharmaceutical Group and Guangzhou Pharmaceutical Group, which are in the forefront of the same industry. But Tai Chi is already learning from them and cooperating with them. The strategic alliance agreement signed last year was the first step of their cooperation. They will jointly promote the development of Chinese medicine and enhance the competitiveness of local pharmaceutical enterprises and foreign pharmaceutical enterprises. Bai also said that Taiji Group has achieved today's achievements because of its good products, good team and good system. Tai Chi will take the health of the broad masses of the people as its own responsibility, constantly explore and innovate, and inject new vitality into the development of medical economy in China.
In the face of GMP and GSP, monetary tightening shows its great influence. At this time, the steady strategy of Taiji Group began to work. Sufficient funds have been prepared for the certification of the company. So far, all the production and operation enterprises of Taiji Group have passed GMP and GSP certification of the State Food and Drug Administration.
As early as 2002, after completing the acquisition of Southwest Pharmaceutical, Bai publicly stated that Taiji Group would not make large-scale acquisitions in recent years, but would focus on the integration of the acquired companies, with "high technology, high efficiency and high efficiency" as the core. This strategic decision of "rest and recuperation" has indeed ensured that Taiji Group will continue to maintain its growth momentum during the period of austerity. With the overall decline of the national pharmaceutical economy, from June 5438 to September this year, Taiji Group's sales reached 5.288 billion yuan, including 200 million yuan in pharmaceutical export trade, with the export trade volume increasing by 35% year-on-year. It is estimated that the annual export trade volume can exceed 500 million yuan. The industrial and commercial sales of the entire Taiji Group increased by 20% year-on-year, and it is not a problem to complete the sales of 7.5 billion yuan in 2004. It is expected to break through10 billion in the past year.
As we all know, the transformation of science and technology into productive forces will produce a qualitative leap, and Taiji Group is making a leap with advanced product research and development and advanced production technology. After GMP certification, the core competitiveness of domestic pharmaceutical industry will focus on varieties. During the integration period, Taiji Group formed a strong scientific research system, which brought a large number of new products with broad market prospects and laid a solid product foundation for the next stage of leap-forward development.
Behind the powerful strength of Taiji Group is a powerful scientific research system formed in recent years, which consists of Chongqing Institute of Traditional Chinese Medicine, Taiji Medicine Research Institute, Taiji Postdoctoral Workstation and five R&D centers.
Among them, Chongqing Institute of Traditional Chinese Medicine is the largest scientific research institution of traditional Chinese medicine in China, with more than 300,000 specimens of traditional Chinese medicine in the world, more than 50 mu of medicinal botanical gardens and 200,000 mu of Cordyceps bases in Kangding and Shiqu. It is estimated that the output of Cordyceps sinensis will reach 6,543.8+billion in 2008, which not only lays a foundation for the industrialization of traditional Chinese medicine, but also promotes the economic development in minority areas.
Taiji also cooperated with Peking University, Academy of Military Medical Sciences, China Pharmaceutical University and other national 15 universities to establish postdoctoral workstations and train more than 20 postdoctoral students. The company has R&D centers all over the world: Beijing New Product Design Center, German Medical Information Center, American Medical Information Center, Sydney Chinese Medicine Research Center, Macau Taiji Co., Ltd. and other institutions responsible for new product design and scientific and technological information collection.
For a long time, Taiji Group has launched a number of well-known superior varieties with unique advantages in resources, technology, equipment, talents and networks, and the research and development of new drugs has formed a benign pattern of development generation, research generation and reserve generation.
Taiji Group owns more than 0/000 varieties of Chinese and Western medicines/KLOC. There are more than 30 varieties produced exclusively in China, more than 20 varieties protected by patents, more than 30 varieties protected by traditional Chinese medicine, and 6 varieties with annual sales exceeding 100 million. Among them, Tylo, the world's most advanced diabetes drug with China patent, the world's first melatonin controlled release preparation, and Xinshubao, a sleep aid drug with good hypnotic effect and no side effects, have been widely welcomed by the market since its listing. One of the two major weight-loss drugs approved by the United States in the past 30 years, the first weight-loss drug "Qumei" approved by SDA of China, and the first health food "Lycopene Capsule" to protect prostate and breast in China, are at the leading level in China. The "blockbuster" products that can effectively and safely kill verruca plana and condyloma acuminata virus will bring nearly 3 billion yuan of industrial output value to Taiji Group in the next five years, providing sufficient power for its future sustainable development. At the same time, Taiji Group will also develop from a pure Chinese patent medicine manufacturer into a product with international first-class western medicine and China traditional characteristics; Large-scale pharmaceutical industry and trade entities with high-end products and more basic drugs for ordinary people.
The product is an extension of the distant culture, a loyal, United, hardworking and responsible Taiji person, and an ideal to create health and happiness for mankind and improve the quality of life in an all-round way. "The way of civil and military affairs is relaxed one by one". Only when China's classical philosophy is used by Taiji can Taiji develop in a virtuous circle.
Bai is a respected manager of Taiji Group. He believes that "the health industry is the longest-lived industry of mankind and will always be a dynamic industry". Bai said that some people can do many things in their lives, but most people can only do one thing well. Enterprises may involve many industries, but it is not easy to concentrate on making an industry the best. The goal of Taiji Group is clear: to make China's special medicine the best in the world. In order to achieve this goal, Taiji Group has a set of methods of "nourishing qi". Enterprises implement two sets of "teams" in employing people. One team on the job, one team on the job: either do research, go to college for further study, or go abroad for inspection, and then "rotate jobs" after three to five years.
Therefore, employees of Taiji Group have a "hope" for promotion, regardless of their positions. After graduating from college, ordinary salespeople should go to the industry market to exercise first. After their ability reaches a certain level, they will hopefully be promoted to more important positions. When their abilities are released, they have the opportunity to "recharge their batteries": further study and then promotion. The middle and senior managers of Taiji Group have rich conditions: they have the opportunity to go to first-class universities at home or abroad for further study with full salary, and at the same time continue their further study, study the market and learn technology. Up to now, * * * is studying for more than 200 doctors and masters; More than 200 people went to the United States, Europe, Japan, Australia and other countries and regions for training and inspection.
Tai Chi is infinite, a healthy world. The goal of Taiji Group is to exceed 7.5 billion yuan in sales in 2004, 654.38+0 billion yuan in 2005 and 654.38+0.5 billion yuan in 2008. They are determined to welcome guests from all over the world with excellent performance and benefit the people.